parameters | survivors | non-survivors | P-value |
---|---|---|---|
N (%) | 44 (57.1) | 33(42.9) | - |
Age (year) | 69.6 ± 6.5 | 71 ± 7.5 | 0.359 |
Gender (M/F) | 17/27 (38.6/61.4) | 18/15(54.5/45.5) | > 0.05 |
Hospital stay (days) | 14.9 ± 12.5 | 7.5 ± 11.1 | < 0.001 |
ALT (U/L) | 120.6 (49.7, 181.3) | 125.3 (61.5, 202.6) | > 0.05 |
AST (U/L) | 204.3 (110.5, 494.6) | 383.8 (2030.5, 745.5) | > 0.05 |
AST/ALT ratio | 2.57 (1.94, 3.25) | 3.83 (2.53, 4.77) | 0.001 |
GGT (U/L) | 44.5 (23, 144.3) | 55 (26, 176.1) | > 0.05 |
ALP (U/L) | 69.8 (53.3, 188.6) | 99.0 (57.4, 158.5) | > 0.05 |
mAST (U/L) | 54.0 (28.9, 120.8) | 93.6 (59.1, 159.4) | 0.005 |
mAST/AST ratio | 0.25 (0.21, 0.26) | 0.25 (0.23, 0.26) | > 0.05 |
mAST/ALT ratio | 0.58 (0.45, 0.78) | 0.81 (0.63, 1.15) | < 0.001 |
cAST (U/L) | 153.9 (82.4, 376.2) | 292.0 (171.6, 592.7) | 0.012 |
cAST/ALT ratio | 1.97 (1.43, 2.47) | 3.09 (1.80, 3.57) | 0.001 |
hsTnI (pg/ml) | 117.5 (50, 280.6) | 261.9 (90.0, 1914.5) | 0.007 |
CK (U/L) | 610 (270.5, 1292.8) | 925 (474, 2438) | 0.033 |
CK-MB (ng/ml) | 6.59 (3.34, 14.42) | 6.43 (4.05, 15.02) | > 0.05 |
α-HBDH (U/L) | 527.8 (383.1, 864.2) | 1093.9 (614.3, 1068.5) | 0.002 |
LDH (U/L) | 855.5 (521.5, 1543.3) | 1750 (1095.5, 2792.5) | 0.002 |